Search Results for keywords:"pharmaceutical supply chain"

Search Results: keywords:"pharmaceutical supply chain"

H. R. 6802 — To improve supply chain resiliency for critical drug products with vulnerable supply chains and ensure that reserves of critical drugs and active pharmaceutical ingredients are maintained to prevent supply disruptions in the event of drug shortages or public health emergencies.
💰
December 14, 2023
Status:Introduced in House
Congress:118
Words:2,324
The Rolling Active Pharmaceutical Ingredient and Drug Reserve Act, also known as the "RAPID Reserve Act" (H. R. 6802), aims to strengthen the supply chain of critical drugs and their active ingredients in the United States. It authorizes the Secretary of Health and Human...
Simple Explanation
The RAPID Reserve Act is like a plan to store extra medicine in case we run out during emergencies. It wants to make sure important medicines are made at home in the USA and saved up so people can always get them when needed.
H. R. 6992 — To require the Secretary of Health and Human Services to establish a list of essential medicines, and for other purposes.
January 12, 2024
Status:Introduced in House
Congress:118
Words:1,353
H.R. 6992, known as the “Mapping America’s Pharmaceutical Supply Act” or "MAPS Act," instructs the Secretary of Health and Human Services to create and regularly update a list of essential medicines critical to public health and safety. This list focuses on drugs necessary to...
Simple Explanation
The MAPS Act wants to make sure people have the important medicines they need by having a special list and checking where medicines come from so they don't run out during emergencies, while keeping some information secret to stay safe.

Showing 1 to 2 of 2 results